Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
114 Leser
Artikel bewerten:
(0)

AMA Places Ban on cbdMD's CBD Oil Sponsorship of Chad Reed

NEW YORK, NY / ACCESSWIRE / February 19, 2019 / The AMA prohibits CBD sponsorships of all supercross racers for the Monster Energy Supercross until further notice.

The American Motorcyclist Association (AMA) has issued a statement banning CBD sponsorships of the Monster Energy Supercross. This statement disallows any and all CBD sponsorships "with logos or other promotional displays on their person, their uniform, their gear, or on their bike" - and will be enforced by removing any riders who do not comply.

Chad Reed, Australian motocross and supercross racer, and a cbdMD athlete wore the CBD company's logo on his helmet during his race in Minnesota last weekend, however, the AMA will not allow this moving forward, effective immediately.

"We beat ourselves up on the track and cbdMD offers athletes a natural approach to both relief and recovery," said Chad Reed. "I still have hope that the AMA will retract their ruling and recognize the many health benefits that CBD can offer - and not just for athletes, but for everyone."

cbdMD, a Level Brands company (NYSE American: LEVB) and personal sponsor of Reed's, produces THC-free CBD as an all-natural alternative to synthetic medications to alleviate pain, inflammation, sleeplessness, stress, and more. Both amateur and professional athletes continue to look for natural solutions for their aches and pains, and CBD has been pushed to the forefront because of its anti-addictive properties.

"Since our inception, we've remained focused on helping people and making a difference," said Caryn Dunayer, Co-founder and President of cbdMD. "We partner with a number of athletes in many disciplines to promote recovery. Our THC-free products adhere to the industry's highest standards to provide high-quality CBD with health-promoting properties for the masses."

In a statement, the AMA said the rule will remain in effect until further notice.

About cbdMD (http://www.cbdMD.com)

cbdMD, a Level Brands company, offers a comprehensive line of natural, THC-free, hemp-derived CBD oil products made in the US, including tinctures, capsules, gummies, pet products, bath bombs, topicals, and vape oils. As a company committed to the highest standards for CBD sourcing, extraction, and production, cbdMD is for consumers seeking to experience the full benefits of CBD in a safe, convenient, and cost-effective manner. For more information, please visit http://www.cbdMD.com.

About Level Brands (http://www.levelbrands.com)

Level Brands owns and operates the nationally recognized consumer cannabidiol (CBD) brand cbdMD, whose current products include CBD gummies, CBD tinctures, CBD topical, CBD bath bombs, CBD oils, and CBD pet products. The Company also operates a licensing and corporate brand management businesses under the kathy ireland® Health & Wellness; Ireland Men One (I'M1), and Encore Endeavor One (EE1) brands, as well as a personal products division Beauty & Pin-Ups.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as 'should,' 'may,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'projects,' 'forecasts,' 'expects,' 'plans,' and 'proposes.' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in Level Brands, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2018 as filed with the Securities and Exchange Commission (the "SEC") on December 12, 2018 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of Level Brands, Inc. and are difficult to predict. Level Brands, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.

Public Relations Contact:
Danielle Crary
danielle@cbdMD.com

SOURCE: cbdMD



View source version on accesswire.com:
https://www.accesswire.com/536044/AMA-Places-Ban-on-cbdMDs-CBD-Oil-Sponsorship-of-Chad-Reed

© 2019 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.